Home | Welcome to Contract Pharma   
Last Updated Saturday, July 26 2014
Print RSS Feed

AMRI Completes Cedarburg Acquisition



Published April 7, 2014
AMRI has completed the acquisition of Cedarburg Pharmaceuticals, Inc. for a total consideration of $41 million, including assumption of certain liabilities.
 
The acquisition of Cedarburg, a contract developer and manufacturer of technically complex API's for both generic and branded drug products, is part of AMRI's strategy to expand its presence as a supplier of custom and complex drug development services and product. Customers will now have access to expanded resources, including development of complex API, expanded scale-up capabilities and large-scale manufacturing.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On